Newborn Screening for Sickle Cell Disease: Technical and Legal Aspects of a German Pilot Study with 38,220 Participants
Figure 1
Decision tree for handling samples of the babies born in the study period (). Samples were excluded if there was no consent for screening (), no consent to store the sample (), and no consent to use the sample in a scientific project (), too little material () or a low AUC on the HPLC machine (). Please note if any hemoglobin variant other than HbS was detected by means of HPLC, this result was also confirmed by CE.
